Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial
1 other identifier
interventional
152
1 country
1
Brief Summary
Alzheimer's disease (AD) is increasing exponentially, with a projected quadrupling of cases by the mid 21st century. Individuals with AD are at increased risk for a host of medical and psychiatric conditions, and evidence is accumulating supporting the efficacy and effectiveness of psychosocial interventions for improving their mood, function, health, and quality of life. Such interventions are likely to be most effective when they are implemented during the early stages of dementia, when individuals and their family members are coping with the initial diagnosis and associated changes in abilities and activities. Recent randomized clinical trials by the Principal Investigator and colleagues have developed two non-pharmacologic interventions to reduce the social, psychological, physical, and behavioral impact of dementia. This investigation is focused on facilitating their translation into ongoing community-based programs, such as those provided by Alzheimer's Association chapters, senior centers, retirement homes, and other health care providers. The core content of each intervention has been retained in order to maintain or improve their efficacy, and each has been modified to a 4-week group format to increase efficiency of delivery. These modified interventions (ESML-Social and ESML-Ex) will be compared to each other and to a usual care (UC) control group. Outcomes will be assessed at baseline, 1-month post treatment, and 4 month follow-up. Primary outcomes at the 1-month assessment include: social activity participation, family communication, physical activity participation, and physical function. Primary outcomes at 4-month follow up include overall quality of life and depression. It is hypothesized that ESML-Ex and ESML-Social both will have greater improvements than UC. It is hypothesized that ESML-Social will have greater improvements in social participation and family communication than ESML-Ex and UC. It is hypothesized that ESML-Ex will have greater improvements in physical activity participation and physical functioning than ESML-Social and UC. If successful, these 4-week programs may be developed into "modules" that can be incorporated into programming for individuals with early stage dementia in a variety of community settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 5, 2012
CompletedFirst Posted
Study publicly available on registry
March 12, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedJune 10, 2015
June 1, 2015
3 years
March 5, 2012
June 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from Baseline in Social Activity at post-treatment (1 month)
The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.
Baseline and post treatment (1 month)
Change from Baseline in Physical Activity at post-treatment (1 month)
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.
Baseline and post-treatment (1 month)
Change from Baseline in Quality of Life at post-treatment (1 month)
The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.
Baseline and post treatment (1 month)
Change from Baseline in Social Activity at 4 month follow-up
The Pleasant Events Schedule-AD, long version, will be used to evaluate social participation and activity.
Baseline and 4 month follow-up
Change from Baseline in Physical Activity at 4 month follow-up
The Physical Activity Scale for the Elderly (PASE) will be used to assess level of physical activity of participants and care partners.
Baseline and 4 month follow-up
Change from Baseline in Quality of Life at 4 month follow-up
The Quality of Life-AD (QOL-AD)scale will measure quality of life domains identified as important for cognitively impaired older adults.
Baseline and 4 month follow-up
Secondary Outcomes (6)
Change from Baseline in Communication at post-treatment (1 month)
Baseline and post treatment (1 month)
Change from Baseline in Physical Function at post-treatment (1 month)
Baseline and post treatment (1 month)
Change from Baseline in Mood at post-treatment (1 month)
Baseline and post-treatment (1 month)
Change from Baseline in Communication at post-treatment (1 month)
Baseline and post-treatment (1 month)
Change from Baseline in Physical Functioning at post-treatment (1 month)
Baseline and post-treatment (1 month)
- +1 more secondary outcomes
Study Arms (3)
ESML-Exercise (Physical Activity Program)
ACTIVE COMPARATORESML-Exercise consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic. Classes are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the class gets individual attention and that all exercises are done safely using proper form.
ESML-SOCIAL (Social Activity Program)
ACTIVE COMPARATORESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session. Seminars are carried out in small groups of five to six participant/care partner dyads (10-12 people total), to ensure everyone in the seminar gets individual attention and that everyone has a chance to bring up any concerns.
No Intervention
NO INTERVENTIONThis arm will receive no intervention during the active treatment period. After the 4 month assessment participants can choose to attend a support group.
Interventions
ESML-EX consists of four weekly 90-minute classes. Each class includes exercises and a brief discussion of a specific health topic.
ESML-SOCIAL consists of four weekly 90-minute seminars. Each seminar includes discussion of a specific topic, open time for socializing, and a "homework" assignment to be completed prior to the next session.
Eligibility Criteria
You may qualify if:
- Dementia diagnosis
- Clinical Dementia Rating Scale score
- Care Partner agrees to participate with care recipient
- Care recipient lives in the community or a retirement home
- Both care partner and recipient speak English
You may not qualify if:
- Significant physical or psychiatric illness in either care partner or care recipient that would prevent participant in a exercise program
- Planning to move out of study area during the 4 month follow-up period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UWashington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rebecca G Logsdon, Ph.D.
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Professor
Study Record Dates
First Submitted
March 5, 2012
First Posted
March 12, 2012
Study Start
February 1, 2012
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
June 10, 2015
Record last verified: 2015-06